Brazil sets a new chapter in its public health policy

During a seminar hosted by the Brazilian Association of the Pharmaceutical Research Industry (INTERFARMA) last week in Brasilia, the Minister of Health, Luiz Henrique Mandetta, said the country should never compulsory license drug patents, since this practice harms both the inventiveness and the investments made in R&D by private companies. This sets a new tone on the government’s position towards intellectual property for pharmaceutical products. 

Brazil sets a new chapter in its public health policy

Read Full Article…

Proposal authorizes BRPTO to conclude agreements and partnerships to streamline patents

Bill #2334/19 authorizes the signature of covenants or partnerships between the Brazilian Patent and Trademark Office (BRPTO) and public or private entities. The text seeks to alter the Brazilian IP Statute(9.279/96), which also refers to the authority’s competences.   

Proposal authorizes BRPTO to conclude agreements and partnerships to streamline patents

Read Full Article…